MetLife Inc. Sees Modest Earnings Growth Amid Reinsurance Strategy Shift

MetLife Inc. delivered a resilient financial performance in the fourth quarter of 2025, posting adjusted earnings per share of $1.65, surpassing the consensus estimate of $1.60. The result reflects strong results in its individual life insurance segment, where operating income rose 8% year-over-year, supported by improved mortality experience and disciplined pricing adjustments. The company’s reinsurance strategy underwent a notable change, with MetLife entering into a $1.2 billion retroactive reinsurance agreement to transfer long-term care insurance liabilities. This move reduced the company’s exposure to long-term care claims and freed up capital, contributing to a 2.3% increase in adjusted operating return on equity to 9.4%. The reinsurance structure was designed to enhance balance sheet flexibility and support future capital deployment. Despite elevated interest rates, MetLife’s investment portfolio generated net investment income of $1.18 billion for the quarter, up 5% from the prior-year period. The firm maintained a strong capital position, with a common equity tier 1 ratio of 14.7%, well above regulatory thresholds. However, group insurance premiums declined 3.1% sequentially due to client attrition in the corporate market, offsetting gains in other segments. The stock, MET, gained 1.4% in pre-market trading on the report, outperforming the XLF ETF (XLV) and the S&P 500 (^GSPC), which rose 0.3% and 0.2% respectively. Analysts noted that the reinsurance initiative could reduce future earnings volatility, though concerns remain around long-term care claim trends and competitive pressures in the group benefits space.